Fortrea logo
FTREFortrea
Trade FTRE now
Fortrea primary media

About Fortrea

Fortrea Holdings (NASDAQ:FTRE) a global leader in contract research organizations (CROs), assists pharmaceutical, biotechnology, and medical device companies in bringing new treatments and technologies to market. They don't directly offer products or services to consumers, but instead, provide comprehensive solutions throughout the drug and device development process. This includes managing clinical trials, ensuring regulatory compliance, and analyzing data. By supporting the research and development of innovative healthcare solutions, Fortrea plays a crucial role in advancing healthcare and improving patient outcomes.

What is FTRE known for?

Snapshot

Public US
Ownership
2023
Year founded
9037
Employees
North Carolina, United States
Head office
1 of 3
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Produtos e/ou serviços de Fortrea

  • Clinical Trial Management: Fortrea manages all aspects of clinical trials, including study design, site selection, patient recruitment, data collection, and regulatory compliance.
  • Clinical Pharmacology: They offer services related to the study of how drugs and devices affect the human body, ensuring their safety and efficacy.
  • Patient Access Solutions: Fortrea facilitates patient access to clinical trials by removing barriers and ensuring diverse participation across various demographics and geographical regions. This may include patient recruitment strategies, reimbursement assistance, and travel coordination.
  • Regulatory Consulting: They provide expert advice and guidance to navigate the complex regulatory landscape of drug and device development, ensuring compliance with all relevant regulations.
  • Data Analysis and Reporting: Fortrea analyzes and reports clinical trial data, providing valuable insights to sponsors and regulatory agencies.
  • Clinical Trial Project Management & Monitoring: They oversee all aspects of clinical trials, ensuring they are conducted ethically, efficiently, and meet all scientific and regulatory standards.

equipe executiva do Fortrea

  • Ms. Jill McConnellChief Financial Officer
  • Mr. Mark A. MoraisCOO & President of Clinical Services
  • Mr. Anshul ThakralCEO & Director
  • Mr. Drayton VirklerPresident & Chief Commercial Officer
  • Mr. Robert ParksChief Accounting Officer
  • Mr. Alejandro Martinez GalindoChief Information Officer
  • Mr. Dave CooperChief Administrative Officer
  • Ms. Tracy H. KrummeSenior VP of Investor Relations
  • Ms. Agnieszka M. Gallagher J.D.General Counsel
  • Ms. Hima B. InguvaHead of Corporate Development

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.